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Using a conditional mutagenesis strategy we demonstrate here that a gene cluster encoding putative
aminoarabinose (Ara4N) biosynthesis enzymes is essential for the viability of Burkholderia cenocepacia. Loss of
viability is associated with dramatic changes in bacterial cell morphology and ultrastructure, increased
permeability to propidium iodide, and sensitivity to sodium dodecyl sulfate, suggesting a general cell envelope
defect caused by the lack of Ara4N.
Cationic antimicrobial peptides (APs), a group of structur-
ally diverse molecules found in all eukaryotes (17, 34), can kill
gram-positive and gram-negative bacteria, fungi, and viruses
and also modulate innate immune responses (30). In gram-
negative bacteria, APs interact with lipopolysaccharide (LPS)
and via the self-promoted uptake pathway reach targets in the
plasma membrane (16). LPS is a major surface component of
gram-negative bacteria, consisting of O antigen polysaccha-
ride, core oligosaccharide, and lipid A (29). Phosphate groups
covalently attached to residues on the lipid A and core oligo-
saccharide provide sites for electrostatic interactions with APs
(18). Bacteria can resist APs by modifying their lipid A with
4-amino-4-deoxy-L-arabinose (Ara4N), effectively reducing the
net negative charge of LPS molecules. In all species examined
to date, this is a highly regulated process in response to envi-
ronmental Mg2 limitation, excess Fe3, or the presence of
APs (1, 8, 9, 12, 15, 24). However, LPS modification with
Ara4N is dispensable for growth in vitro under routine labo-
ratory conditions.
Burkholderia cenocepacia belongs to the B. cepacia complex,
a group of closely related environmental bacteria that are
emerging opportunistic pathogens of cystic fibrosis patients
and other immunocompromised individuals (23). They are
highly resistant to the majority of clinically useful antimicrobi-
als and also resistant to APs even at concentrations that kill
other bacteria with Ara4N-modified LPS (21). Very little is
known about the mechanism of resistance to APs in Burkhold-
eria spp. LPS from various Burkholderia species, such as B.
cepacia, B. caryophylli, and B. cenocepacia, contains Ara4N
residues in the lipid A and also the unusual glycero-talo-octu-
losonic acid (Ko) residue in the inner-core oligosaccharide (10,
13, 19, 20, 25, 26, 31, 32). Here, we show that a putative gene
cluster for Ara4N biosynthesis and LPS modification is essen-
tial for the viability of B. cenocepacia.
A putative gene cluster for Ara4N biosynthesis in B. ceno-
cepacia. A region spanning nucleotides 2128443 to 2135736 in
chromosome 1 of B. cenocepacia strain J2315 (http://www
.sanger.ac.uk/Projects/B_cenocepacia/) contains genes encod-
ing proteins that are highly similar to those required for Ara4N
biosynthesis and lipid A modification in Salmonella and other
bacteria (14) (Fig. 1A). These genes correspond to homologues
of arnT (pmrK, Ara4N transferase), BCAL1930 (pmrLM, un-
known function), arnB (pmrH, UDP-4-ketopentose amino-
transferase), arnC (pmrF, Ara4N Und-P transferase), and
BCAL1935 (pmrJ, unknown function) (Fig. 1A). Also, unlike
other bacteria in which arnA (pmrI) is a single gene encoding
a bifunctional enzyme (3, 4), two distinct genes are found in B.
cenocepacia which we have designated arnA1 (UDP-Ara4N
formyltransferase) and arnA2 (UDP-4-keto-5-carboxypen-
tose decarboxylase) (Fig. 1A). The transcriptional organization
of the putative B. cenocepacia arn gene cluster was experimen-
tally determined by nested reverse transcriptase PCR (RT-
PCR) amplifications, as previously described (27). We pre-
pared cDNA from total RNA isolated from strain J2315 grown
to logarithmic phase in Luria-Bertani broth with or without
polymyxin B (100 g/ml) and amplified it by PCR using primer
pairs that would allow detection of cotranscription. All PCRs
were performed alongside appropriate controls, including a
non-RT control to assay for genomic DNA contamination.
Primers used for RT-PCR analysis are available from the au-
thors upon request. These experiments demonstrated that the
putative arn genes are organized into two transcriptional units
(Fig. 1B). One unit comprises arnT and BCAL1930, while the
other includes the arn gene loci BCA1A2, BCAL1935, and
BCAL1936 (Fig. 1A). This genetic organization suggests that
the B. cenocepacia genes for the synthesis of UDP-Ara4N (arn
BCA1A2) are transcribed independently from those for trans-
ferring Ara4N to the lipid A (arnT and possibly BCAL1930).
The same genetic organization of the arn cluster was demon-
strated for B. cenocepacia strain K56-2 (data not shown), which
is clonally related to J2315 (22) but is more amenable to ge-
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netic manipulations. RT-PCR analysis also revealed that the
arn cluster in both strains was expressed regardless of poly-
myxin B challenge (data not shown), indicating that it is not
subjected to the same transcriptional regulation as has been
observed in all other bacteria examined to date (1, 24). To
facilitate genetic manipulations the remaining studies were
performed using strain K56-2, which is also highly resistant to
APs (21).
The putative Ara4N biosynthesis cluster is essential for vi-
ability of B. cenocepacia. Repeated attempts to mutagenize
arnT, arnB, arnC, and BCAL1935 by insertional inactivation
using the pGPTp suicide plasmid (11) containing internal
fragments from each target gene consistently failed. In con-
trast, the genes BCAL1928 and BCAL1936 that flank each end
of the putative arn cluster were readily mutated. We hypoth-
esized that the putative arn genes perform one or more func-
tions that are essential for the viability of B. cenocepacia. To
confirm the essentiality of the arn genes, we constructed plas-
mid pSC200, which enables the delivery of the rhamnose-in-
ducible PrhaB promoter into the chromosome to drive the ex-
pression of a targeted gene. The construction of pSC200 was
done by combining the multiple-cloning site, oriR6K, and mob
genes from pGpTp (11) with the PrhaB rhamnose-inducible
promoter, rhaR, rhaS, and the dhfr cassette from pSCrhaB2
(7). Details on the construction of this plasmid are available
from the authors upon request. Several 300-bp fragments span-
ning the 5 region of each targeted gene were cloned into
pSC200. The resulting plasmids were transferred into B. ceno-
cepacia K56-2 by triparental mating, and the exconjugants were
plated on LB agar plates supplemented with trimethoprim
(Tp) (100 g/ml), gentamicin (50 g/ml), and 0.5% (wt/vol)
rhamnose. The correct insertion in the B. cenocepacia chromo-
some was confirmed by colony PCR and Southern blot hybrid-
ization. This strategy created conditional mutants in which the
expression of the targeted gene depended on the rhamnose
concentration in the medium. We have shown that the PrhaB
promoter is useful for characterizing essential operons in B.
cenocepacia (6). Thus, we constructed conditional mutants
by insertion of pSC200 derivatives upstream of arnT (strain
XOA11) and arnB (strain XOA12) as well as a mutant in which
this plasmid interrupts the gene locus BCAL1928 (strain
XOA10) and which served as a negative control (Fig. 1A).
Also, as a positive control for essentiality, a pSC200 derivative
was used to target the conserved essential gene dxs encoding a
key enzyme for the synthesis of undecaprenyl phosphate (2,
28), resulting in strain STC280.
The conditional mutants were grown at 37°C in M9 minimal
medium (42 mM Na2HPO4, 22 mM KH2PO4, 8 mM NaCl, 10
mM NH4Cl) supplemented with (final concentrations) yeast
extract (5 mg/ml), Casamino Acids (2 mg/ml), vitamin B1 (2
g/ml), tryptophan (20 g/ml), CaCl2 (1 M), and 0.5% (wt/
vol) glycerol plus 0.5% (wt/vol) glucose or 0.5% (wt/vol)
rhamnose and Tp (100 g/ml) when required. An aliquot of an
overnight culture in M9 medium with rhamnose was spun
down and washed three times with sterile phosphate-buffered
saline (PBS), resuspended in PBS, and adjusted to an optical
density at 600 nm (OD600) of 1. Drops (10 l) of undiluted
solution and 101, 102, 103, and 104 dilutions were plated
onto M9 agar plates supplemented with 0.5% (wt/vol) glucose
or 0.5% (wt/vol) rhamnose and incubated at 37°C. Strain
STC280 grew in the presence of rhamnose (permissive condi-
tion) but failed to grow in the presence of glucose (nonper-
missive condition), as expected for a mutant with an essential
gene under the control of PrhaB. A similar growth phenotype
was found for XOA11 and XOA12, but XOA10 grew equally
well in the presence of rhamnose or glucose (Fig. 2A). We
FIG. 1. (A) Genetic organization of the putative arn gene cluster and flanking regions on chromosome 1 of B. cenocepacia strains J2315 and
K56-2. Solid boxes around gene and locus names indicate the genes for which polar mutations failed; dotted boxes indicate genes for which the
creation of polar mutations was successful. Mutagenesis of the remaining genes was not attempted. The dotted arrows indicate the locations of
the inserted rhamnose-inducible promoter in strains XOA10, XOA11, and XOA12. Black and gray arrows denote the genes within the two
transcriptional units of the putative arn cluster that were identified by RT-PCR. (B) RT-PCR analysis of the arn cluster, performed on strain J2315
in the absence of polymyxin B challenge.
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therefore concluded that expression of one or more genes in
the two transcriptional units of the putative arn cluster is in-
dispensable in B. cenocepacia K56-2.
The first biochemical reaction for the biosynthesis of
Ara4N is the conversion of UDP-glucose into UDP-gluc-
uronic acid by the enzyme UDP-glucose 6-dehydrogenase
(Ugd or PmrE). In previous work, we characterized a gene
operon containing a ugd homologue (BCAL2946) and genes
encoding modification of glycero-manno-heptose, which are
part of the biosynthesis of the ADP-glycero-manno-heptose
precursor for core oligosaccharide biosynthesis (21). To as-
sess whether or not ugdBCAL2946 is also essential, we con-
structed a conditional ugdBCAL2946 mutant (SAL10). This
mutant did not show a conditional lethal phenotype in me-
dium with glucose (Fig. 2A), indicating that ugdBCAL2946 is
not essential for bacterial viability. A BLAST analysis of the
B. cenocepacia J2315 genome revealed the presence of two
additional ugd homologues in chromosome 2 (BCAM0855
and BCAM2034), which we assume provide redundant UDP-
glucose dehydrogenase activities.
Loss of viability is associated with morphological changes in
the bacterial cells and defects in cell envelope permeability.
The essentiality of Ara4N synthesis was further demonstrated
by depletion experiments performed using liquid medium (Fig.
2B). Eight-hour cultures were diluted to an OD600 of 0.001 in
M9 medium supplemented with 5% (wt/vol) yeast extract and
0.5% (wt/vol) rhamnose and incubated at 37°C for 11 h. Cells
from these cultures were spun down, washed three times with
sterile PBS, and diluted with fresh M9 medium supplemented
with 5% (wt/vol) yeast extract and 0.5% (wt/vol) glucose at a
final OD600 of 0.13. Growing cells were subcultured with fresh
medium containing 0.5% (wt/vol) glucose at 4 h and monitored
for growth for another 6 h. Growth curves of the wild-type
strain and all the mutants in permissive conditions were iden-
tical (data not shown). After serial passages in medium with
glucose, the wild type and the XOA10 mutant also grew to
similar levels (Fig. 2B). In contrast, after serial passage in
medium with glucose of XOA11 and XOA12 cultures, the
turbidity of the cultures rapidly reached a plateau compared to
wild-type and XOA10 control strain results. The results indi-
cate that XOA11 and XOA12 had stopped growing after 6 h
(roughly corresponding to six generations). Phase-contrast mi-
croscopy and fluorescent staining with Syto9 and propidium
iodide (LIVE/DEAD BacLight bacterial viability kit; Molecu-
lar Probes, Invitrogen Detection Technologies, Eugene, OR)
were carried out to investigate the bacterial cell morphology
and to assess whether or not the cell envelope was compro-
mised. After 8 h in nonpermissive conditions, strains XOA11
and XOA12, but not K56-2 and XOA10, formed chains of cells
and the cultures contained flocculent particulate material in-
dicative of cell lysis. Also, 50% of XOA11 and 58% of XOA12
bacterial cells were permeable to propidium iodide in contrast
to 5% to 10% of the control strains, suggesting a loss of
viability and a compromised cell envelope in the arn condi-
tional mutants (Fig. 3). No differences in morphology or via-
bility were observed between these same strains grown over-
night under permissive conditions before being transferred to
the nonpermissive medium for the depletion experiments (data
not shown).
Ultrastructural analysis of bacterial cells after 8 h following
depletion revealed accumulations of membranous material in
strains XOA11 and XOA12 (Fig. 4), suggesting that Ara4N is
required for the proper assembly of the outer membrane. Fur-
thermore, empty cells and cells with cell division defects could
be observed in the mutant cultures (Fig. 4). To obtain further
evidence that the envelope was compromised in XOA11 and
XOA12 under nonpermissive conditions, bacteria were grown
in the presence of 0.05% (wt/vol) sodium dodecyl sulfate
(SDS). For these experiments, cells were diluted to an OD600
of 0.1 and dilutions were plated for colony counts on M9 agar
plates supplemented with 5% (wt/vol) yeast extract, 0.5% (wt/
vol) rhamnose, and Tp (100 g/ml) with or without 0.05%
(wt/vol) SDS. The survival rate of K56-2 cells in the presence
of SDS was 1.2% of the initial inoculum, while the survival
rates of XOA11 and XOA12 cells were 0.09% and 0.08%,
respectively. Together, these experiments demonstrate that the
putative arn gene cluster is essential for B. cenocepacia viability
and that its function is required for an intact cell envelope. It
is possible that LPS modifications with Ara4N are an essential
requirement for the stability of the outer membrane in this
FIG. 2. (A) Conditional lethal phenotype of strains XOA11 and
XOA12 on M9 agar plates supplemented with 0.5% (wt/vol) rhamnose
or 0.5% (wt/vol) glucose. XOA11 and XOA12 grow only in the pres-
ence of rhamnose, while XOA10 and SAL10 grow equally well in
either media. STC280 is shown as a control mutant for a known
essential gene. (B) Depletion experiments using strains K56-
2(pSCrhaB2), XOA10, XOA11, and XOA12 in nonpermissive condi-
tions. Growth was monitored every hour using a Klett-Summerson
colorimeter. The figure is representative of two independent experi-
ments with similar results.
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FIG. 3. Microscopy and live-dead staining of strains K56-2, XOA10, XOA11, and XOA12 at 8 h of growth during the depletion experiments.
Live bacteria appear fluorescent green, while dead bacteria and bacteria with compromised membranes appear fluorescent red. These experiments
were carried out twice with similar results.
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group of bacteria, which may explain at least in part their
extreme resistance to APs. Recent structural studies of the
lipid A moiety of B. cepacia (formerly genomovar I) and B.
mallei revealed that only a proportion of lipid A species are
nonstoichiometrically replaced with Ara4N (5, 31), although
we do not know whether this is also the case for the lipid A
from B. cenocepacia. Perhaps not all the lipid A molecules are
required to be replaced with Ara4N to maintain the stability of
the outer membrane. Furthermore, our results did not conclu-
sively establish whether or not Ara4N is essential in the lipid A
and/or the inner core oligosaccharide. The morphological de-
fects of the mutants under nonpermissive conditions are strik-
ingly similar to those found in Escherichia coli mutants with
defects in the Imp/RlpB complex, which is essential for proper
assembly of LPS in the outer membrane (33). Therefore, it is
possible that the products encoded by the putative arn gene
cluster in B. cenocepacia are also required for the assembly of
LPS in this bacterium. A detailed biochemical analysis of the
lipid A biosynthesis in B. cenocepacia, currently under way in
our laboratories, will help to elucidate the role of these genes
and will also confirm their predicted function in the synthesis
of Ara4N.
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